The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 15, 2016
Filed:
Apr. 09, 2014
E. R. Squibb & Sons, L.l.c., Princeton, NJ (US);
Ono Pharmaceutical Co., Ltd., Osaka, JP;
Alan J. Korman, Piedmont, CA (US);
Mohan Srinivasan, Cupertino, CA (US);
Changyu Wang, Union City, CA (US);
Mark J. Selby, San Francisco, CA (US);
Bingliang Chen, Alameda, CA (US);
Josephine M. Cardarelli, San Carlos, CA (US);
Haichun Huang, San Carlos, CA (US);
Ono Pharmaceutical Co., Ltd., Osaka, JP;
E.R. Squibb & Sons, L.L.C., Princeton, NJ (US);
Abstract
The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to PD-1 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The invention also provides methods for detecting PD-1, as well as methods for treating various diseases, including cancer and infectious diseases, using anti-PD-1 antibodies. The present invention further provides methods for using a combination immunotherapy, such as the combination of anti-CTLA-4 and anti-PD-1 antibodies, to treat hyperproliferative disease, such as cancer. The invention also provides methods for altering adverse events related to treatment with such antibodies individually.